The Hyris Values
The Hyris Values
Vision
Hyris is driven by a vision to offer its clients an integrated testing solution that incorporates all the elements needed to deploy a network of biosensing units: any environment, any field.
Excellence
The company is based on a product excellence strategy, delivering significant advantages to its clients and allowing a much larger cohort of users to deploy genetic testing solutions for the medical, veterinary and agrofood industries.
Experience
Clients that wish to execute specific genetic tests may choose from an increasing number of end user solutions the one that fits their need. All of these are suitable for both experienced personnel and front line operators.
Tailor-made
Partners that require customized development can use the Hyris platform to their advantage, implementing and deploying specifically targeted solutions.
The Hyris Team
The Hyris Team
Hyris’ partners and management contribute to the company’s effort to build world-class client centered solutions with relevant experiences in the fields of:
- 15 years’ experience in cooperating with the major players in biomedical systems in developing and transitioning to manufacturing some of the best known products in the field
- Decades of experience in commercializing high tech products, deployment and implementation of commercial strategies, account management and technical support for clients ranging from small research centers to Fortune 500 global corporations
- A technical team with a diverse and deep background in microsystems R&D, plant biology, medical technology, banking software interfaces and more.
Hyris’ investors include professionals with a long and successful track record in financial management, M&A, tech companies. The company is engaged with a number of world-class corporations and partners in the joint development of targeted testing solutions.
Milestones
Milestones
- October 2014
- July 2015
- October 2015
- January 2016
- April 2016
- May 2016
- October 2016
- May 2017
- July 2017
- August 2017
- March 2018
- August 2018
- April 2019
- June 2019
- April 2020
- September 2020
-
October 2014
Hyris Ltd founded in London, UK -
July 2015
R&D facilities open in Milan, Italy -
October 2015
Hyris obtains EPPO certification for a plant pathology reagent kit -
January 2016
bCUBE1.0 completes first successful run -
April 2016
First client orders booked, third party integration activities start -
May 2016
Key customers demos and technical codevelopment. First commercial revenues booked. -
October 2016
Hyris obtains the Seal of Excellence of the European Commission -
May 2017
Hyris announces partnership and entry into the Botanicals application area. -
July 2017
First platforms and clients in the plant pathology sector -
August 2017
bCUBE 2.0 available for sale. -
March 2018
Hyris signs strategic partnership agreement for the Botanicals market -
August 2018
Hyris launches its platform and product line for Botanicals plant species identification. -
April 2019
Hyris launches its product line for Probiotics strains identification. -
June 2019
First scientific article in collaboration with the Johns Hopkins University. -
April 2020
Hyris launches its test for the identification of the SARS-CoV-2 on environmental surfaces. -
September 2020
Hyris test for the identification of the SARS-CoV-2 in human specimens is approved for sales in Canada as point-of-care test.
Address
One George Yard
EC3V 9DF - London, UK
-
This email address is being protected from spambots. You need JavaScript enabled to view it.
Main Menu